Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
05 2019
Historique:
received: 21 12 2017
accepted: 12 04 2019
pubmed: 17 5 2019
medline: 7 2 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

Genetic and epigenetic intra-tumoral heterogeneity cooperate to shape the evolutionary course of cancer

Identifiants

pubmed: 31092926
doi: 10.1038/s41586-019-1198-z
pii: 10.1038/s41586-019-1198-z
pmc: PMC6533116
mid: NIHMS1527005
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

576-580

Subventions

Organisme : NCI NIH HHS
ID : R01 CA240910
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA216273
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NIEHS NIH HHS
ID : K01 ES025431
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA206978
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL145283
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA233338
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA229902
Pays : United States
Organisme : NCI NIH HHS
ID : DP2 CA239065
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006516
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Epigenetic plasticity and the hallmarks of cancer. Science 357, eaal2380 (2017).
doi: 10.1126/science.aal2380
Burger, J. A. et al. Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition. Nat. Commun. 7, 11589 (2016).
doi: 10.1038/ncomms11589
Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525–530 (2015).
doi: 10.1038/nature15395
Beekman, R. et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat. Med. 24, 868–880 (2018).
doi: 10.1038/s41591-018-0028-4
Oakes, C. C. et al. DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat. Genet. 48, 253–264 (2016).
doi: 10.1038/ng.3488
Landau, D. A. et al. Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia. Cancer Cell 26, 813–825 (2014).
doi: 10.1016/j.ccell.2014.10.012
Landan, G. et al. Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat. Genet. 44, 1207–1214 (2012).
doi: 10.1038/ng.2442
Shipony, Z. et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature 513, 115–119 (2014).
doi: 10.1038/nature13458
Shibata, D. Mutation and epigenetic molecular clocks in cancer. Carcinogenesis 32, 123–128 (2011).
doi: 10.1093/carcin/bgq239
Hansen, K. D. et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768–775 (2011).
doi: 10.1038/ng.865
Hudson, R. R. & Kaplan, N. L. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 111, 147–164 (1985).
pubmed: 1202594 pmcid: 1202594
Chen, T. L. et al. NF-κB p50 (nfkb1) contributes to pathogenesis in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia. Blood 130, 376–379 (2017).
doi: 10.1182/blood-2017-01-761130
Arsura, M., Hofmann, C. S., Golay, J., Introna, M. & Sonenshein, G. E. A. A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation. Blood 96, 1013–1020 (2000).
Qu, Y. et al. Cancer-specific changes in DNA methylation reveal aberrant silencing and activation of enhancers in leukemia. Blood 129, e13–e25 (2017).
doi: 10.1182/blood-2016-07-726877
Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714–726 (2013).
doi: 10.1016/j.cell.2013.01.019
Rendeiro, A. F. et al. Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks. Nat. Commun. 7, 11938 (2016).
doi: 10.1038/ncomms11938
Sekimata, M. & Homma, Y. Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. Nucleic Acids Res. 32, 590–597 (2004).
doi: 10.1093/nar/gkh249
Grün, D. et al. De novo prediction of stem cell identity using single-cell transcriptome data. Cell Stem Cell 19, 266–277 (2016).
doi: 10.1016/j.stem.2016.05.010
Caron, G. et al. Cell-cycle-dependent reconfiguration of the DNA methylome during terminal differentiation of human B cells into plasma cells. Cell Reports 13, 1059–1071 (2015).
doi: 10.1016/j.celrep.2015.09.051
Sottoriva, A. et al. A Big Bang model of human colorectal tumor growth. Nat. Genet. 47, 209–216 (2015).
doi: 10.1038/ng.3214
Shlush, L. I. et al. Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability. Blood 120, 603–612 (2012).
doi: 10.1182/blood-2011-10-388629
Wang, L. et al. Transcriptomic characterization of SF3B1 mutation reveals its pleiotropic effects in chronic lymphocytic leukemia. Cancer Cell 30, 750–763 (2016).
doi: 10.1016/j.ccell.2016.10.005
Herman, S. E. M. et al. Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia 28, 2188–2196 (2014).
doi: 10.1038/leu.2014.122
Satterwhite, E. et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98, 3413–3420 (2001).
doi: 10.1182/blood.V98.12.3413
Herndon, T. M. et al. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia 31, 1340–1347 (2017).
doi: 10.1038/leu.2017.11
Phelan, J. D. et al. A multiprotein supercomplex controlling oncogenic signalling in lymphoma. Nature 560, 387–391 (2018).
doi: 10.1038/s41586-018-0290-0
Herishanu, Y. et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 117, 563–574 (2011).
doi: 10.1182/blood-2010-05-284984
Dadashian, E. L. et al. TLR signaling is activated in lymph-node resident CLL cells and is only partially inhibited by ibrutinib. Cancer Res. 79, 360–371 (2019).
doi: 10.1158/0008-5472.CAN-18-0781
Siegmund, K. D., Marjoram, P., Woo, Y.-J., Tavaré, S. & Shibata, D. Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc. Natl Acad. Sci. USA 106, 4828–4833 (2009).
doi: 10.1073/pnas.0810276106
Messmer, B. T. et al. In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 115, 755–764 (2005).
doi: 10.1172/JCI23409
Rassenti, L. Z. et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112, 1923–1930 (2008).
doi: 10.1182/blood-2007-05-092882
Guo, H. et al. Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing. Nat. Protocols 10, 645–659 (2015).
doi: 10.1038/nprot.2015.039
Guo, H. et al. Single-cell methylome landscapes of mouse embryonic stem cells and early embryos analyzed using reduced representation bisulfite sequencing. Genome Res. 23, 2126–2135 (2013).
doi: 10.1101/gr.161679.113
Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics 27, 1571–1572 (2011).
doi: 10.1093/bioinformatics/btr167
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
doi: 10.1038/nmeth.1923
Macaulay, I. C. et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat. Methods 12, 519–522 (2015).
doi: 10.1038/nmeth.3370
Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protocols 9, 171–181 (2014).
doi: 10.1038/nprot.2014.006
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
doi: 10.1093/bioinformatics/bts635
Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012).
doi: 10.1101/gr.135350.111
Van den Berge, K. et al. Observation weights unlock bulk RNA-seq tools for zero inflation and single-cell applications. Genome Biol. 19, 24 (2018).
doi: 10.1186/s13059-018-1406-4
Risso, D., Perraudeau, F., Gribkova, S., Dudoit, S. & Vert, J. P. A general and flexible method for signal extraction from single-cell RNA-seq data. Nat. Commun. 9, 284 (2018).
doi: 10.1038/s41467-017-02554-5
Van den Berge, K., Soneson, C., Robinson, M. D. & Clement, L. stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage. Genome Biol. 18, 151 (2017).
doi: 10.1186/s13059-017-1277-0
Illingworth, R. S. et al. Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet. 6, e1001134 (2010).
doi: 10.1371/journal.pgen.1001134
Andersson, R. et al. An atlas of active enhancers across human cell types and tissues. Nature 507, 455–461 (2014).
doi: 10.1038/nature12787
The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
doi: 10.1038/nature11247
Jurka, J. Repbase update: a database and an electronic journal of repetitive elements. Trends Genet. 16, 418–420 (2000).
doi: 10.1016/S0168-9525(00)02093-X
O’Geen, H., Echipare, L. & Farnham, P. J. in Epigenetics Protocols (ed. Tollefsbol, T. O.) 265–286 (Humana Press, 2011).
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
doi: 10.1093/bioinformatics/btp324
Zhang, Y. et al. Model-based analysis of ChIP–seq (MACS). Genome Biol. 9, R137 (2008).
doi: 10.1186/gb-2008-9-9-r137
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102
Tajima, F. Infinite-allele model and infinite-site model in population genetics. J. Genet. 75, 27 (1996).
doi: 10.1007/BF02931749
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
doi: 10.1093/bioinformatics/btq033
Machanick, P. & Bailey, T. L. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27, 1696–1697 (2011).
doi: 10.1093/bioinformatics/btr189
Gupta, S., Stamatoyannopoulos, J. A., Bailey, T. L. & Noble, W. S. Quantifying similarity between motifs. Genome Biol. 8, R24 (2007).
doi: 10.1186/gb-2007-8-2-r24
Ushijima, T. et al. Fidelity of the methylation pattern and its variation in the genome. Genome Res. 13, 868–874 (2003).
doi: 10.1101/gr.969603
Biezuner, T. et al. A generic, cost-effective, and scalable cell lineage analysis platform. Genome Res. 26, 1588–1599 (2016).
doi: 10.1101/gr.202903.115
Navin, N. et al. Tumour evolution inferred by single-cell sequencing. Nature 472, 90–94 (2011).
doi: 10.1038/nature09807
Bian, S. et al. Single-cell multiomics sequencing and analyses of human colorectal cancer. Science 362, 1060–1063 (2018).
doi: 10.1126/science.aao3791
de Bourcy, C. F. A. et al. Phylogenetic analysis of the human antibody repertoire reveals quantitative signatures of immune senescence and aging. Proc. Natl Acad. Sci. USA 114, 1105–1110 (2017).
doi: 10.1073/pnas.1617959114
Xu, J. et al. Single-cell lineage tracing by endogenous mutations enriched in transposase accessible mitochondrial DNA. eLife 8, e45105 (2019).
Ludwig, L. S. et al. Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics. Cell 176, 1325–1339 (2019).
doi: 10.1016/j.cell.2019.01.022
Nguyen, L.-T., Schmidt, H. A., von Haeseler, A. & Minh, B. Q. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol. Biol. Evol. 32, 268–274 (2015).
doi: 10.1093/molbev/msu300
Zhou, X., Shen, X.-X., Hittinger, C. T. & Rokas, A. Evaluating fast maximum likelihood-based phylogenetic programs using empirical phylogenomic data sets. Mol. Biol. Evol. 35, 486–503 (2018).
doi: 10.1093/molbev/msx302
Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A. & Jermiin, L. S. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat. Methods 14, 587–589 (2017).
doi: 10.1038/nmeth.4285
Soubrier, J. et al. The influence of rate heterogeneity among sites on the time dependence of molecular rates. Mol. Biol. Evol. 29, 3345–3358 (2012).
doi: 10.1093/molbev/mss140
Hoang, D. T., Chernomor, O., von Haeseler, A., Minh, B. Q. & Vinh, L. S. UFBoot2: Improving the ultrafast bootstrap approximation. Mol. Biol. Evol. 35, 518–522 (2017).
doi: 10.1093/molbev/msx281
Robinson, D. F. & Foulds, L. R. Comparison of phylogenetic trees. Math. Biosci. 53, 131–147 (1981).
doi: 10.1016/0025-5564(81)90043-2
Raval, A. et al. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia. J. Clin. Oncol. 23, 3877–3885 (2005).
doi: 10.1200/JCO.2005.02.196
Perez, C. A., Ott, J., Mays, D. J. & Pietenpol, J. A. p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm. Oncogene 26, 7363–7370 (2007).
doi: 10.1038/sj.onc.1210561
Hsiao, L.-L. et al. A compendium of gene expression in normal human tissues. Physiol. Genomics 7, 97–104 (2001).
doi: 10.1152/physiolgenomics.00040.2001
Wilhelm, M. et al. Mass-spectrometry-based draft of the human proteome. Nature 509, 582–587 (2014).
doi: 10.1038/nature13319

Auteurs

Federico Gaiti (F)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Ronan Chaligne (R)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Hongcang Gu (H)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Ryan M Brand (RM)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Steven Kothen-Hill (S)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Rafael C Schulman (RC)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Kirill Grigorev (K)

Weill Cornell Medicine, New York, NY, USA.

Davide Risso (D)

Weill Cornell Medicine, New York, NY, USA.
Department of Statistical Sciences, University of Padova, Padova, Italy.

Kyu-Tae Kim (KT)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Alessandro Pastore (A)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Kevin Y Huang (KY)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Alicia Alonso (A)

Weill Cornell Medicine, New York, NY, USA.

Caroline Sheridan (C)

Weill Cornell Medicine, New York, NY, USA.

Nathaniel D Omans (ND)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Evan Biederstedt (E)

New York Genome Center, New York, NY, USA.
Weill Cornell Medicine, New York, NY, USA.

Kendell Clement (K)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Lili Wang (L)

Beckman Research Institute, City of Hope, Monrovia, CA, USA.

Joshua A Felsenfeld (JA)

Weill Cornell Medicine, New York, NY, USA.

Erica B Bhavsar (EB)

Weill Cornell Medicine, New York, NY, USA.

Martin J Aryee (MJ)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

John N Allan (JN)

Weill Cornell Medicine, New York, NY, USA.

Richard Furman (R)

Weill Cornell Medicine, New York, NY, USA.

Andreas Gnirke (A)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Catherine J Wu (CJ)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Dana-Farber Cancer Institute, Boston, MA, USA.

Alexander Meissner (A)

Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Max Planck Institute for Molecular Genetics, Berlin, Germany.

Dan A Landau (DA)

New York Genome Center, New York, NY, USA. dlandau@nygenome.org.
Weill Cornell Medicine, New York, NY, USA. dlandau@nygenome.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH